Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment.
作者信息
Muric Nemanja N, Arsenijevic Nebojsa N, Borovcanin Milica M
机构信息
Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Psychiatric Clinic, Clinical Center Kragujevac, Kragujevac, Serbia.
出版信息
Front Psychiatry. 2020 Dec 23;11:612347. doi: 10.3389/fpsyt.2020.612347. eCollection 2020.
Abstract
摘要
相似文献
1
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment.氯丙嗪作为新冠病毒肺炎治疗中一种潜在的抗精神病药物选择
Front Psychiatry. 2020 Dec 23;11:612347. doi: 10.3389/fpsyt.2020.612347. eCollection 2020.
2
Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.新冠疫情期间的精神病治疗及吩噻嗪类药物的潜在作用：呼吁开展研究
J Clin Psychopharmacol. 2020 Nov/Dec;40(6):641-642. doi: 10.1097/JCP.0000000000001310.
3
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.首例新冠肺炎患者出现躁狂样症状，该患者既往无精神障碍病史。
J Affect Disord. 2020 Dec 1;277:337-340. doi: 10.1016/j.jad.2020.08.031. Epub 2020 Aug 20.
4
Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.日本吞咽与吞咽困难学会：关于COVID-19疫情期间吞咽困难管理的立场声明。
Auris Nasus Larynx. 2020 Oct;47(5):715-726. doi: 10.1016/j.anl.2020.07.009. Epub 2020 Jul 23.
5
Severe exacerbation of psychosis after sudden withdrawal of chlorpromazine in the treatment of methamphetamine-associated psychosis with aripiprazole and chlorpromazine: 2 case reports.使用阿立哌唑和氯丙嗪治疗甲基苯丙胺所致精神病时，突然停用氯丙嗪后精神病性症状严重加剧：2例报告
J Addict Med. 2014 Nov-Dec;8(6):479-81. doi: 10.1097/ADM.0000000000000061.
6
Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation.严重急性呼吸综合征冠状病毒感染后身体功能和体能的变化与恢复的系统评价：对 COVID-19 康复的启示。
Phys Ther. 2020 Sep 28;100(10):1717-1729. doi: 10.1093/ptj/pzaa129.
7
The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.从 RT-PCR 咽拭子检测阴性的患者向他人传播 SARS-CoV-2 的可能性：两起新冠肺炎暴发的聚集性疫情。
Jpn J Infect Dis. 2020 Nov 24;73(6):399-403. doi: 10.7883/yoken.JJID.2020.165. Epub 2020 May 29.
8
Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review.新型冠状病毒肺炎的潜在抑制剂和功能性食品成分作为 COVID-19 的营养补充剂：综述。
Plant Foods Hum Nutr. 2020 Dec;75(4):458-466. doi: 10.1007/s11130-020-00861-9. Epub 2020 Oct 10.
9
Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.新冠病毒感染的输入导致台湾 COVID-19 大流行。
Int J Infect Dis. 2020 Aug;97:240-244. doi: 10.1016/j.ijid.2020.06.031. Epub 2020 Jun 13.
10
Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS.新型冠状病毒肺炎对母婴结局的潜在影响：借鉴严重急性呼吸综合征的经验教训
Front Pediatr. 2020 Aug 7;8:511. doi: 10.3389/fped.2020.00511. eCollection 2020.
引用本文的文献
1
Study of the Lipophilicity of Tetracyclic Anticancer Azaphenothiazines.四环抗癌氮杂吩噻嗪类化合物亲脂性的研究
Biomolecules. 2025 Aug 19;15(8):1194. doi: 10.3390/biom15081194.
2
DRaW: prediction of COVID-19 antivirals by deep learning-an objection on using matrix factorization.DRaW：深度学习预测 COVID-19 抗病毒药物——对使用矩阵分解的反对意见。
BMC Bioinformatics. 2023 Feb 15;24(1):52. doi: 10.1186/s12859-023-05181-8.
3
Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution.在新冠病毒感染中开具选择性5-羟色胺再摄取抑制剂需谨慎。
Front Psychiatry. 2022 Oct 19;13:1052710. doi: 10.3389/fpsyt.2022.1052710. eCollection 2022.
4
Sigma-1 Receptor Ligands Chlorpromazine and Trifluoperazine Attenuate Ca Responses in Rat Peritoneal Macrophages.西格玛-1受体配体氯丙嗪和三氟拉嗪减弱大鼠腹腔巨噬细胞中的钙反应。
Cell tissue biol. 2022;16(3):233-244. doi: 10.1134/S1990519X22030075. Epub 2022 May 27.
5
Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy.氯丙嗪通过诱导 G2/M 细胞周期阻滞、细胞凋亡和自噬抑制结直肠癌和肺转移。
Cancer Chemother Pharmacol. 2022 Mar;89(3):331-346. doi: 10.1007/s00280-021-04386-z. Epub 2022 Jan 24.
6
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort.慢性精神科住院患者队列中抗抑郁药及其他药物对新冠病毒感染风险影响的分析
BJPsych Open. 2021 Dec 3;8(1):e6. doi: 10.1192/bjo.2021.1053.
7
A Multidisciplinary Approach to Coronavirus Disease (COVID-19).冠状病毒病（COVID-19）的多学科处理方法。
Molecules. 2021 Jun 9;26(12):3526. doi: 10.3390/molecules26123526.
8
Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants.利用 DockThor-VS 网络服务器进行药物设计和再利用，重点关注 SARS-CoV-2 的治疗靶点及其非同义变体。
Sci Rep. 2021 Mar 10;11(1):5543. doi: 10.1038/s41598-021-84700-0.
本文引用的文献
1
Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic.新冠疫情期间心理神经免疫学的动态变化
Brain Behav Immun Health. 2020 May;5:100096. doi: 10.1016/j.bbih.2020.100096. Epub 2020 Jun 15.
2
Psychiatry and COVID-19: The Role of Chlorpromazine.精神病学与新冠病毒-19：氯丙嗪的作用
Can J Psychiatry. 2020 Oct;65(10):739-740. doi: 10.1177/0706743720934997. Epub 2020 Jun 15.
3
Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes.COVID-19 感染的遗传途径：对风险、严重程度和结果的影响。
FASEB J. 2020 Jul;34(7):8787-8795. doi: 10.1096/fj.202001115R. Epub 2020 Jun 11.
4
New-onset psychosis in COVID-19 pandemic: a case series in Madrid.新冠疫情期间的新发精神病：马德里的病例系列
Psychiatry Res. 2020 Aug;290:113097. doi: 10.1016/j.psychres.2020.113097. Epub 2020 May 13.
5
The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.重新审视 COVID-19 相关神经学：世界神经病学联合会环境神经病学专业组提出实施国际神经学登记的建议。
J Neurol Sci. 2020 Jul 15;414:116884. doi: 10.1016/j.jns.2020.116884. Epub 2020 May 7.
6
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用：恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
7
Impact of coronavirus outbreak on psychological health.冠状病毒爆发对心理健康的影响。
J Glob Health. 2020 Jun;10(1):010331. doi: 10.7189/jogh.10.010331.
8
COVID-19: ICU delirium management during SARS-CoV-2 pandemic.COVID-19：SARS-CoV-2 大流行期间 ICU 谵妄管理。
Crit Care. 2020 Apr 28;24(1):176. doi: 10.1186/s13054-020-02882-x.
9
Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.我们是否正面临着一波 COVID-19 神经精神后遗症的浪潮？神经精神症状和潜在的免疫机制。
Brain Behav Immun. 2020 Jul;87:34-39. doi: 10.1016/j.bbi.2020.04.027. Epub 2020 Apr 13.
10
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).新型冠状病毒病 2019（COVID-19）的流行病学、诊断、治疗和疫苗的现状。
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011.
Zotero 插件